US Patent Issued to Akamis Bio on July 8 for "Dosing regime and formulations for type B adenoviruses" (British Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,350,302, issued on July 8, was assigned to Akamis Bio Ltd. (Abingdon, Great Britain).

"Dosing regime and formulations for type B adenoviruses" was invented by John Beadle (Abingdon, Great Britain), Kerry Fisher (Abingdon, Great Britain) and Christine Wilkinson Blanc (Abingdon, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides a method of treating a human patient comprising the steps of: systematically administering multiple doses of a parenteral formulation of a replication capable oncolytic adenovirus of subgroup B in a single treatment cycle, wherein the total dose given in each dose is in the range of 1x1010 ...